bpc-157 peptide human clinical trial – Prime Labs The amounts people discuss for
Description
Not intended for human or animal consumption, diagnosis, treatment, or prevention of any disease
Display borderline insulin resistance or early metabolic syndrome
Targeted Fat Burning (Beyond Obesity) That gentler action puts AOD9604 into an interesting category, where it doesnt only have potential as a weight loss peptide for treating overweight and obesity, but also for stubborn fat deposits in non-obese subjects
e0162590
In animal studies, AOD-9604 treatment reduced body weight gain by over 50% compared to controls over a 19-day period, with increased lipolytic activity in adipose tissue
